Prosecution Insights
Last updated: April 19, 2026

Oncocross Co. Ltd.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18286068 COMPOUND FOR PREVENTING OR TREATING DIABETES REDWOOD, CHRISTOPHER EVAN 1629 Non-Final OA Oct 06, 2023
18285820 COMPOUND FOR PREVENTION OR TREATMENT OF KIDNEY DISEASE DEKARSKE, MADELINE MCGUIRE 1622 Non-Final OA Oct 05, 2023
18278664 METHOD FOR DETERMINING PRIMARY TUMOR SITE GIAMMONA, FRANCESCA FILIPPA 1681 Non-Final OA Aug 24, 2023
17918977 METHOD FOR ESTIMATING TISSUE-LEVEL INFORMATION FROM CELLULAR-LEVEL INFORMATION, AND DEVICE THEREFOR RUIZ, JOSHUA DAMIAN 3684 Non-Final OA Oct 14, 2022

Managing Oncocross Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month